戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  trials of alternative devices using holmium:yttrium-aluminum-garnet and eximer lasers are underway.
2 copic therapy, including formalin, neodymium/yttrium aluminum garnet, argon and potassium titanyl pho
3 ery, 35.6% of patients underwent a neodymium:yttrium-aluminum-garnet capsulotomy in the iMics1 NY-60
4  significant difference in PCO and neodymium:yttrium-aluminum-garnet capsulotomy rate 3 years after s
5 of the optic disc was obscured, or neodymium-yttrium-aluminum-garnet capsulotomy was performed.
6 s (57.9%), 9 eyes (47.4%) required neodymium-yttrium-aluminum-garnet capsulotomy, and 3 eyes (15.8%)
7 ave demonstrated that a Q-switched neodymium:yttrium-aluminum-garnet dermatology laser kills larval m
8 lculated the modulation transfer function of yttrium-aluminum-garnet doped with cerium, anthracene, a
9 ith a single application of either an erbium:yttrium-aluminum-garnet (Er:YAG) (2,940-nm) laser or a d
10 ifferent photoablative dental lasers, erbium:yttrium-aluminum-garnet (Er:YAG) and diode, for the trea
11                       The efficacy of erbium:yttrium-aluminum-garnet (Er:YAG) laser application as an
12 ventional ultrasonic scaler versus an erbium:yttrium-aluminum-garnet (Er:YAG) laser on titanium surfa
13 ities including carbon dioxide (CO2), erbium:yttrium-aluminum-garnet (Er:YAG), pulsed dye (PDL), and
14                                      Holmium:yttrium-aluminum-garnet (Ho:YAG) laser endoureterotomy i
15                      Swine underwent holmium:yttrium-aluminum-garnet (holmium:YAG) (n = 12) or carbon
16    Animals then underwent TMR with a holmium:yttrium-aluminum-garnet (holmium:YAG) laser (n = 5), TMI
17            The latter consisted of neodymium:yttrium-aluminum-garnet hyaloidotomy in the 5 eyes with
18 ration was stimulated in vivo with a Holmium:yttrium aluminum garnet laser (2.12 microm), free electr
19 tle evidence that using a diode or neodymium:yttrium-aluminum-garnet laser adds clinical value over a
20 he introduction of the side-firing neodymium:yttrium-aluminum-garnet laser in the early 1990s laser p
21 er-diameter optic fiber coupled to a holmium:yttrium-aluminum-garnet laser or a 400-micrometer-diamet
22 t, including thermal ablation with neodymium:yttrium-aluminum-garnet laser, argon plasma coagulation,
23 ise endoscopic lithotrites like the holmium: yttrium-aluminum-garnet laser.
24 itched, frequency-doubled Nd:YAG (neodymium, yttrium, aluminum, garnet) laser operating at 532 nm to
25                             The holmium:YAG (Yttrium-Aluminum-Garnet) laser lithotripter is able to d
26 chial amyloidosis required Nd:YAG (neodymium:yttrium-aluminum-garnet) laser therapy for obstructive s
27 the combination of carbon dioxide and erbium:yttrium-aluminum-garnet lasers to achieve improved resul
28 derwent percutaneous Biosense-guided holmium:yttrium aluminum garnet LMR to areas of viable but ische
29   A 532 nm frequency doubled neodymium-doped yttrium aluminum garnet (ND:YAG) laser was used to creat
30 llow-emitting phosphor, such as cerium-doped yttrium aluminum garnet or (YAG):Ce(3+), coupled with a
31               Additional procedures, such as yttrium aluminum garnet (YAG) capsulotomies or reduction
32 r capsular opacification and neodymium-doped yttrium-aluminum-garnet (YAG) laser capsulotomy, and sur
33 Medicare beneficiary proximity to his or her yttrium-aluminum-garnet (YAG) laser capsulotomy-providin
34                     The mid-infrared holmium:yttrium-aluminum-garnet (YAG) laser has been shown to be
35 silluminator, 488-nm argon-ion laser, 532-nm yttrium-aluminum-garnet (YAG) laser, blue fluorescent li

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。